Home / Netherlands / Lakefront Biotherapeutics NV

Lakefront Biotherapeutics NV

No short position is open on this share today.

0.00% of the capital sold short

0 disclosing funds

689 disclosures on record

Evolution of the disclosed total

0%1%2%3%

Oct 2025Jan 2026Apr 2026Jul 2026

Sum of open short positions, as % of capital. Hover or tap the curve to see which funds make it up.

Over the whole history, the total peaked at 5.00% on May 21, 2018. The shaded band matches the twelve months of the first chart.

July 31, 2015 today

Open positions

No fund discloses a short position on this share today. The History of disclosures table lists the ones that existed.

Follow by RSS

Get the moves on Lakefront Biotherapeutics NV by mail.

There is no account to create. You give an address, you confirm it through a link, and every message contains a link to stop.

History of disclosures

689 disclosures on record for this share.
Date	Fund	% of capital
November 14, 2019	Citadel Advisors LLC	0.52%
November 11, 2019	Marshall Wace LLP	0.88%
November 11, 2019	Citadel Advisors LLC	0.49%
November 8, 2019	AQR Capital Management, LLC	1.58%
November 7, 2019	AQR Capital Management, LLC	1.65%
November 6, 2019	Marshall Wace LLP	0.99%
November 5, 2019	AQR Capital Management, LLC	1.77%
November 5, 2019	Citadel Advisors LLC	0.53%
November 4, 2019	D. E. Shaw & Co., L.P.	1.01%
October 31, 2019	AQR Capital Management, LLC	1.89%
October 30, 2019	Marshall Wace LLP	1.09%
October 29, 2019	D. E. Shaw & Co., L.P.	0.98%
October 29, 2019	Citadel Advisors LLC	0.46%
October 28, 2019	D. E. Shaw & Co., L.P.	1.00%
October 28, 2019	Citadel Advisors LLC	0.59%
October 25, 2019	Marshall Wace LLP	1.10%
October 25, 2019	Citadel Advisors LLC	0.69%
October 24, 2019	D. E. Shaw & Co., L.P.	1.10%
October 18, 2019	D. E. Shaw & Co., L.P.	1.02%
October 18, 2019	Marshall Wace LLP	0.90%
October 17, 2019	D. E. Shaw & Co., L.P.	0.99%
October 10, 2019	D. E. Shaw & Co., L.P.	1.01%
October 9, 2019	D. E. Shaw & Co., L.P.	0.99%
October 9, 2019	Citadel Advisors LLC	0.79%
October 4, 2019	D. E. Shaw & Co., L.P.	1.01%
October 1, 2019	AQR Capital Management, LLC	1.93%
October 1, 2019	Marshall Wace LLP	0.81%
September 27, 2019	Marshall Wace LLP	0.70%
September 24, 2019	Marshall Wace LLP	0.60%
September 20, 2019	AQR Capital Management, LLC	1.89%
September 18, 2019	AQR Capital Management, LLC	1.90%
September 12, 2019	AQR Capital Management, LLC	1.84%
September 10, 2019	D. E. Shaw & Co., L.P.	0.98%
September 9, 2019	Citadel Advisors LLC	0.80%
September 6, 2019	AQR Capital Management, LLC	1.70%
September 4, 2019	D. E. Shaw & Co., L.P.	1.00%
September 3, 2019	Citadel Advisors LLC	0.71%
August 28, 2019	AQR Capital Management, LLC	1.66%
August 28, 2019	Citadel Advisors LLC	0.67%
August 26, 2019	D. E. Shaw & Co., L.P.	0.95%
August 23, 2019	Citadel Advisors LLC	0.72%
August 19, 2019	Citadel Advisors LLC	0.60%
August 16, 2019	D. E. Shaw & Co., L.P.	1.01%
August 14, 2019	Citadel Advisors LLC	0.50%
August 13, 2019	D. E. Shaw & Co., L.P.	0.91%
August 7, 2019	D. E. Shaw & Co., L.P.	0.80%
July 24, 2019	D. E. Shaw & Co., L.P.	0.70%
July 23, 2019	AQR Capital Management, LLC	1.84%
July 22, 2019	D. E. Shaw & Co., L.P.	0.60%
July 19, 2019	Marshall Wace LLP	0.56%

Download 689 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats

Other companies sold short in the Netherlands

Akzo Nobel N.V. 9.86% of the capital sold short
Pharming Group N.V. 7.95% of the capital sold short
Signify N.V. 7.52% of the capital sold short
Imcd N.V. 4.65% of the capital sold short
Fugro N.V. 4.20% of the capital sold short
DSM-Firmenich AG 3.48% of the capital sold short
Basic-Fit N.V. 3.43% of the capital sold short
PostNL N.V. 2.55% of the capital sold short
NSI N.V. 2.01% of the capital sold short
Alfen N.V. 1.85% of the capital sold short
Arcadis N.V. 1.72% of the capital sold short
Sligro Food Group N.V. 1.55% of the capital sold short

Cite this page

The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.

QuiVad, Lakefront Biotherapeutics NV, source AFM, data as at April 2, 2026, https://www.quivad.com/action/lakefront-biotherapeutics-nv?page=8